Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Fennec Pharmaceuticals Inc banner
F

Fennec Pharmaceuticals Inc
F:RV41

Watchlist Manager
Fennec Pharmaceuticals Inc
F:RV41
Watchlist
Price: 9.4 EUR -12.15% Market Closed
Market Cap: €256.8m
Write Note Create Alert Ask AI

Wall St Price Targets

RV41 Price Targets Summary
Fennec Pharmaceuticals Inc

Wall Street analysts forecast RV41 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RV41 is 12.4 EUR with a low forecast of 10.91 EUR and a high forecast of 14.18 EUR.

RV41 Lowest Forecast
Wall Street Target
€10.91
16% Upside
RV41 Average Forecast
Wall Street Target
€12.4
32% Upside
RV41 Highest Forecast
Wall Street Target
€14.18
51% Upside
Lowest Forecast
Price Target
10.91 EUR
16% Upside
Average Forecast
Price Target
12.4 EUR
32% Upside
Highest Forecast
Price Target
14.18 EUR
51% Upside
Fennec Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

The compound annual growth rate for Revenue over the next 8 years is 24%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Gross Profit over the next 8 years is 24%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

What are analyst estimates?

Continue RV41 Research

Summary
RV41 intrinsic value, competitors valuation, and company profile.
DCF Valuation
RV41 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RV41 stock valuation using valuation multiples.
Wall St Estimates
RV41 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RV41 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Fennec Pharmaceuticals Inc listings:
NASDAQ • USD
FENC
 TSX • CAD
FRX
 SWB • EUR
RV41
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RV41's stock price target?
Price Target
12.4 EUR

According to Wall Street analysts, the average 1-year price target for RV41 is 12.4 EUR with a low forecast of 10.91 EUR and a high forecast of 14.18 EUR.

What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%

The compound annual growth rate for Revenue over the next 8 years is 24%.

What is the Gross Profit forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%

The compound annual growth rate for Gross Profit over the next 8 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.